Latest Articles

Publication Date
Diet and physical activity coaching for well-being and pain reduction in patients with symptomatic endometriosis: a randomized-controlled clinical trial.

Pain is a defining symptom of endometriosis reducing quality of life and increasing the risk of psychological disorders. We conducted an open-label, randomized, controlled trial to investigate whether structured coaching …

Published: Aug. 17, 2026, midnight
Dual Intrauterine Device Placement for Refractory Endometriosis Pain in a Bicornuate Uterus: A Case Report.

A 27-year-old nulliparous woman presented with chronic pelvic pain (CPP) (8/10 on the Numerical Rating Scale (NRS)), dysmenorrhea, heavy menstrual bleeding (HMB), and a family history of endometriosis. She had …

Published: Aug. 17, 2026, midnight
Ovarian Carcinoma Presenting Mucoepidermoid Carcinoma-Like Features in Association With Seromucinous Borderline Tumor: A Real Seromucinous Carcinoma?

Ovarian seromucinous carcinoma is generally classified within the spectrum of endometrioid carcinoma. We report a rare ovarian carcinoma with mucoepidermoid carcinoma-like features arising in direct association with a seromucinous borderline …

Published: Aug. 15, 2026, midnight
Effect of deoxyribonuclease I therapy on free circulating DNA level and gene methylation profile changes in patients with endometriosis: Proof of concept and preliminary data.

ObjectiveEndometriosis is a systemic chronic disease with serious effects on various aspects of female health and wellbeing that has been associated with a significant increase in free circulating DNA (CfDNA) …

Published: Aug. 14, 2026, midnight
Adolescent dysmenorrhea revealing Herlyn-Werner-Wunderlich syndrome with endometriosis: A radiologic case report.

Herlyn-Werner-Wunderlich syndrome, also referred to as obstructed hemivagina with ipsilateral renal agenesis (OHVIRA) is a rare congenital urogenital anomaly resulting from abnormal development of the Müllerian and Wolffian ducts, classically …

Published: Aug. 14, 2026, midnight
FocalTherics Reports Q2 2026 Revenue of $13.2M; Net Loss $14.5M - TradingView

FocalTherics Reports Q2 2026 Revenue of $13.2M; Net Loss $14.5M TradingView

Published: Aug. 13, 2026, 8:03 p.m.
FocalTherics™ Reports Second Quarter 2026 Financial Results - GlobeNewswire

FocalTherics™ Reports Second Quarter 2026 Financial Results GlobeNewswire

Published: Aug. 13, 2026, 8:02 p.m.
Karyopharm reports Q2 2026: $33.4M revenue, $67.0M net loss; myelofibrosis sNDA on track - TradingView

Karyopharm reports Q2 2026: $33.4M revenue, $67.0M net loss; myelofibrosis sNDA on track TradingView

Published: Aug. 13, 2026, 11:43 a.m.
Synchronous right colon adenocarcinoma and sigmoid endometriosis mimicking a second primary carcinoma: a case report.

Intestinal endometriosis is a benign gynecological condition that frequently involves the rectosigmoid colon. Its synchronous occurrence with colorectal cancer is exceptionally rare and diagnostically challenging, particularly when mimicking a second …

Published: Aug. 13, 2026, midnight
Legislating infrastructure: a state-level model to accelerate endometriosis research and women's health equity.

Impact statement: A legislatively mandated, statewide endometriosis biorepository integrated within a multidisciplinary endometriosis focused program demonstrates how policy-driven infrastructure can integrate education, clinical care, harmonized biobanking, and translational research to …

Published: Aug. 13, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!